For laboratory research use only — not for human or veterinary use. Not evaluated by the U.S. FDA.
Neuropeptide
SEMAX
A synthetic ACTH(4-10) analog studied for its effects on BDNF expression and TrkB signaling in cognitive and neuroprotection research.
Quantity
$29.99
Bundle & save
Delivery
Order by 3:00 PM ET for same-day dispatch
Cutoff 3:00 PM ET · same-day dispatch
Estimated arrival in 2–3 business days
Overnight shipping available
Free shipment protection included
SEMAX
1 × 10mg · $29.99
99% purity, QC passed
HPLC + mass-spec verified
Shipment protection
Free on every order
Free shipping over $150
Same-day dispatch before 3PM ET
Certificate of Analysis
Third-party tested · Independent analytical lab
10mg
99.14%latest
| Tested | Measured | Purity |
|---|---|---|
| Jul 2026 | 11.32mg | 99.14% |
| Jun 2026 | 11.92mg | 99.02% |
| May 2026 | 12.15mg | 98.28% |
| May 2026 | 11.83mg | 98.46% |
| Mar 2026 | 12.87mg | 98.91% |
| Feb 2026 | 11.69mg | 99.57% |
| Dec 2025 | 11.96mg | 99.13% |
| Dec 2025 | 11.80mg | 99.67% |
| Dec 2025 | 12.40mg | 98.78% |
| Oct 2025 | 11.85mg | 99.53% |
Frequently researched together
Commonly studied alongside SEMAX.
Compound information
Technical specifications
Molecular profile
| Type | Synthetic heptapeptide |
| CAS number | 80714-61-0 |
| Molecular weight | 813.9 g/mol |
| Amino acids | 7 |
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro |
| Formula | C37H51N9O10S |
Storage & stability
- ❄️
Lyophilized (powder)
-20°C · stable 2+ years
- ❄️
Reconstituted
2–8°C · use within 30 days
Sources & references
Peer-reviewed literature, for research context
- Brain Research
Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus
2006·DOI: 10.1016/j.brainres.2006.07.108·PMID: 16996037Dolotov OV, Karpenko EA, Inozemtseva LS, et al.
View source - BMC Genomics
The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis
2014·DOI: 10.1186/1471-2164-15-228·PMID: 24661604Medvedeva EV, Dmitrieva VG, Povarova OV, et al.
View source - Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
The efficacy of semax in the treatment of patients at different stages of ischemic stroke
2018·PMID: 29798983View source - Journal of Molecular Neuroscience
Comparison of the temporary dynamics of NGF and BDNF gene expression in rat hippocampus, frontal cortex, and retina under Semax action
2010·DOI: 10.1007/s12031-009-9270-z·PMID: 19662538Shadrina M, Kolomin T, Agapova T, et al.
View source - Genes
Novel Insights into the Protective Properties of ACTH((4-7))PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats
2020·DOI: 10.3390/genes11060681·PMID: 32580520View source
Important research notice
Not for human consumption. This product is sold exclusively for laboratory and in vitro research. It is not intended to diagnose, treat, cure, or prevent any disease.
Any research findings referenced on this page are drawn from published, peer-reviewed literature and are provided for educational context only. They are not product claims and should not be read as medical advice.
By purchasing, you confirm you are a qualified researcher and will handle this material in accordance with all applicable laws and institutional guidelines.